Summary
69 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $1.10B against $120.8M.
- Out of every 100 USD of revenue, 18 USD is left as free cash.
- It bought back its own shares for $465.9M in the last fiscal year, 4.2% of its market value.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue growth is slowing: 2.6% a year over the last 3 years against 10% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.7 USD for 1 USD of yearly profit. Over the last five years it was 45.1 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 2.6% a year. For the next fiscal year analysts expect revenue to grow by 2.8%. Earnings per share grew by 7.0% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 34 USD
- Research and development 9.1 USD
- Sales and administration 44 USD
- Taxes and other 3.3 USD
- Net profit 10.0 USD
Net profit, industry median (Medical - Devices) 6.9 USD
Out of every 100 USD of revenue, 10.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 22
- Hold 9
- Sell 2
Today's price within the analysts' price targets
The average target of $205.25 is 33% above today's price. 67% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Clear Aligner 80%
- Scanners And Services 20%
By region
- UNITED STATES 41%
- Other International 36%
- SWITZERLAND 23%
Clear Aligner brings in 80% of revenue. Scanners And Services grew fastest, by 2.9% a year.
Segments in detail